United States · FDA National Drug Code directory
BOSULIF
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-0504_ca8600d9-46e6-402d-89f9-bc6a156bf751
- Product NDC
- 0069-0504
- Form
- CAPSULE
- Composition / generic term
- Bosutinib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240102
- Source listing expiry
- 20271231
Source-listed ingredients
- BOSUTINIB MONOHYDRATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (0069-0504-30) · 0069-0504-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →